Sanara Medtech Stock

Sanara Medtech Equity 2024

Sanara Medtech Equity

44.83 M USD

Ticker

SMTI

ISIN

US79957L1008

In 2024, Sanara Medtech's equity was 44.83 M USD, a 7.18% increase from the 41.83 M USD equity in the previous year.

Sanara Medtech Aktienanalyse

What does Sanara Medtech do?

Sanara Medtech Inc is a leading company specializing in the development of innovative medical devices and solutions. The company is headquartered in Texas, USA and has experienced significant growth since its founding in 2014. Its areas of specialization include wound care, incontinence management, and dermatology. The history of Sanara Medtech Inc began in 2014 when a team of experienced medical technology experts founded the company. Leveraging their extensive industry knowledge and expertise, the team quickly identified a market niche and established themselves as a leading provider of innovative solutions. The business model of Sanara Medtech Inc is focused on developing medical devices and solutions that aim to improve the daily lives of patients and healthcare professionals. The company is committed to developing and manufacturing top-quality products that contribute to enhancing patient care and supporting healthcare professionals in their tasks. Sanara Medtech Inc offers a wide range of products tailored to the needs of patients and medical professionals. Its wound care products include wound dressings, wound healing ointments, and other specialized products for treating chronic and acute wounds. The incontinence management products include disposable and reusable incontinence products designed to improve the lives of individuals with incontinence issues. Dermatology products encompass a wide range of products for treating skin conditions such as psoriasis, eczema, and rosacea, to name a few. Another focus of Sanara Medtech Inc is collaborating with private and public healthcare facilities to ensure the availability of its products in hospitals, clinics, nursing homes, and other healthcare facilities. The company also offers training and educational programs for healthcare professionals to ensure proper product use. In summary, Sanara Medtech Inc is an innovative company specializing in the development of medical devices and solutions tailored to the needs of patients and healthcare professionals. Its goal is to develop top-quality products that contribute to the improvement of healthcare and enhance the lives of patients. With a wide range of products and a strong market presence, Sanara Medtech Inc is a leading force in the medical technology industry. Sanara Medtech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Sanara Medtech's Equity

Sanara Medtech's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Sanara Medtech's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Sanara Medtech's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Sanara Medtech's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Sanara Medtech’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Sanara Medtech stock

What is the equity of Sanara Medtech this year?

Sanara Medtech has equity of 44.83 M USD this year.

What was the equity of Sanara Medtech compared to the previous year?

The equity of Sanara Medtech has increased/decreased by 7.18% increased compared to the previous year.

What impact does a high equity have on investors of Sanara Medtech?

A high equity is advantageous for investors of Sanara Medtech as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Sanara Medtech?

A low equity can be a risk for investors of Sanara Medtech, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Sanara Medtech affect the company?

An increase in equity of Sanara Medtech can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Sanara Medtech affect the company?

A reduction in equity of Sanara Medtech can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Sanara Medtech?

Some factors that can affect the equity of Sanara Medtech include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Sanara Medtech so important for investors?

The equity of Sanara Medtech is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Sanara Medtech take to change the equity?

To change equity, Sanara Medtech can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Sanara Medtech pay?

Over the past 12 months, Sanara Medtech paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Sanara Medtech is expected to pay a dividend of 0 USD.

What is the dividend yield of Sanara Medtech?

The current dividend yield of Sanara Medtech is .

When does Sanara Medtech pay dividends?

Sanara Medtech pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Sanara Medtech?

Sanara Medtech paid dividends every year for the past 0 years.

What is the dividend of Sanara Medtech?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Sanara Medtech located?

Sanara Medtech is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sanara Medtech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sanara Medtech from 9/17/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/17/2024.

When did Sanara Medtech pay the last dividend?

The last dividend was paid out on 9/17/2024.

What was the dividend of Sanara Medtech in the year 2023?

In the year 2023, Sanara Medtech distributed 0 USD as dividends.

In which currency does Sanara Medtech pay out the dividend?

The dividends of Sanara Medtech are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Sanara Medtech

Our stock analysis for Sanara Medtech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sanara Medtech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.